Chapter 5. Immune Dysregulation: Potential Mediator of Metabolic Syndrome—Induced Cardiac Remodeling

  1. Ronald Ross Watson1,2 and
  2. Douglas F. Larson3
  1. Sherma Zibadi,
  2. Douglas F. Larson and
  3. Ronald Ross Watson

Published Online: 15 APR 2008

DOI: 10.1002/9780470692325.ch5

Immune Dysfunction and Immunotherapy in Heart Disease

Immune Dysfunction and Immunotherapy in Heart Disease

How to Cite

Zibadi, S., Larson, D. F. and Watson, R. R. (2007) Immune Dysregulation: Potential Mediator of Metabolic Syndrome—Induced Cardiac Remodeling, in Immune Dysfunction and Immunotherapy in Heart Disease (eds R. R. Watson and D. F. Larson), Blackwell Publishing Ltd, Oxford, UK. doi: 10.1002/9780470692325.ch5

Editor Information

  1. 1

    Department of Nutritional Sciences, The University of Arizona; and Sarver Heart Center, College of Medicine, The University of Arizona

  2. 2

    Division of Health Promotion Sciences, Mel and Enid Zuckerman Arizona College of Public Health, The University of Arizona Tucson, AZ USA

  3. 3

    Sarver Heart Center College of Medicine The University of Arizona Tucson, AZ USA

Publication History

  1. Published Online: 15 APR 2008
  2. Published Print: 30 AUG 2007

ISBN Information

Print ISBN: 9781405155687

Online ISBN: 9780470692325

SEARCH

Keywords:

  • immune dysregulation;
  • cardiac remodeling;
  • insulin;
  • cholestrol;
  • diastolic function

Summary

This chapter contains section titled:

  • Introduction

  • Definition and prevalence of Mets

  • Pathophysiology of Mets

  • Left ventricular remodeling and myocardial dysfunction

  • TH1/TH2 imbalance: a potential mediator of LV remodeling in Mets

  • Conclusion

  • Acknowledgment

  • References